- Home
- ASPI vs SIBN Comparison
ASPI vs SIBN Comparison
Compare ASPI & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- SIBN
- Stock Information
- Founded
- ASPI 2021
- SIBN 2008
- Country
- ASPI United States
- SIBN United States
- Employees
- ASPI N/A
- SIBN N/A
- Industry
- ASPI Major Chemicals
- SIBN Medical/Dental Instruments
- Sector
- ASPI Industrials
- SIBN Health Care
- Exchange
- ASPI Nasdaq
- SIBN Nasdaq
- Market Cap
- ASPI 653.4M
- SIBN 717.0M
- IPO Year
- ASPI 2022
- SIBN 2018
- Fundamental
- Price
- ASPI $8.21
- SIBN $16.29
- Analyst Decision
- ASPI Strong Buy
- SIBN Strong Buy
- Analyst Count
- ASPI 1
- SIBN 4
- Target Price
- ASPI $11.00
- SIBN $25.75
- AVG Volume (30 Days)
- ASPI 5.2M
- SIBN 338.7K
- Earning Date
- ASPI 08-14-2025
- SIBN 08-04-2025
- Dividend Yield
- ASPI N/A
- SIBN N/A
- EPS Growth
- ASPI N/A
- SIBN N/A
- EPS
- ASPI N/A
- SIBN N/A
- Revenue
- ASPI $4,581,523.00
- SIBN $185,262,000.00
- Revenue This Year
- ASPI $512.64
- SIBN $19.92
- Revenue Next Year
- ASPI $181.15
- SIBN $16.28
- P/E Ratio
- ASPI N/A
- SIBN N/A
- Revenue Growth
- ASPI 99.57
- SIBN 22.93
- 52 Week Low
- ASPI $2.11
- SIBN $11.70
- 52 Week High
- ASPI $11.68
- SIBN $20.05
- Technical
- Relative Strength Index (RSI)
- ASPI 41.60
- SIBN 48.65
- Support Level
- ASPI $8.35
- SIBN $15.95
- Resistance Level
- ASPI $10.87
- SIBN $16.88
- Average True Range (ATR)
- ASPI 0.71
- SIBN 0.49
- MACD
- ASPI -0.25
- SIBN 0.10
- Stochastic Oscillator
- ASPI 16.19
- SIBN 60.14
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.